Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$212K Hold
75,000
0.01% 313
2022
Q2
$188K Hold
75,000
0.01% 343
2022
Q1
$242K Hold
75,000
0.01% 342
2021
Q4
$210K Sell
75,000
-25,000
-25% -$71.6K 0.01% 389
2021
Q3
$276K Hold
100,000
0.01% 340
2021
Q2
$344K Hold
100,000
0.01% 292
2021
Q1
$274K Hold
100,000
0.01% 336
2020
Q4
$306K Hold
100,000
0.01% 278
2020
Q3
$226K Hold
100,000
0.01% 304
2020
Q2
$264K Hold
100,000
0.01% 259
2020
Q1
$230K Hold
100,000
0.02% 226
2019
Q4
$466K Hold
100,000
0.02% 166
2019
Q3
$462K Hold
100,000
0.03% 161
2019
Q2
$467K Hold
100,000
0.02% 152
2019
Q1
$430K Hold
100,000
0.02% 151
2018
Q4
$392K Sell
100,000
-25,000
-20% -$107K 0.03% 138
2018
Q3
$571K Hold
125,000
0.03% 143
2018
Q2
$579K Sell
125,000
-232
-0.2% -$1.36K 0.03% 132
2018
Q1
$910K Buy
125,232
+232
+0.2% +$1.59K 0.05% 97
2017
Q4
$808K Hold
125,000
0.04% 99
2017
Q3
$824K Buy
125,000
+25,000
+25% +$155K 0.05% 101
2017
Q2
$549K Buy
100,000
+30,000
+43% +$171K 0.03% 126
2017
Q1
$403K Sell
70,000
-747
-1% -$4.1K 0.02% 179
2016
Q4
$347K Buy
70,747
+747
+1% +$4.03K 0.02% 181
2016
Q3
$426K Sell
70,000
-5,000
-7% -$29.9K 0.03% 129
2016
Q2
$443K Sell
75,000
-33,000
-31% -$177K 0.03% 111
2016
Q1
$559K Buy
108,000
+8,000
+8% +$36.8K 0.04% 114
2015
Q4
$446K Hold
100,000
0.03% 145
2015
Q3
$490K Hold
100,000
0.03% 135
2015
Q2
$610K Hold
100,000
0.04% 151
2015
Q1
$576K Hold
100,000
0.03% 147
2014
Q4
$622K Hold
100,000
0.04% 152
2014
Q3
$655K Hold
100,000
0.04% 157
2014
Q2
$704K Hold
100,000
0.04% 155
2014
Q1
$741K Sell
100,000
-50,000
-33% -$350K 0.05% 144
2013
Q4
$1.1M Buy
+150,000
New +$1.1M 0.07% 105

Other funds holding ABEV

R.H. Bluestein & Co's ABEV Position: Q3 2022 in Review

R.H. Bluestein & Co held its Ambev (ABEV) position steady in Q3 2022 at 75,000 shares worth $212K. The position accounts for 0.01% of the portfolio, ranked #313.

R.H. Bluestein & Co first reported a position in ABEV in Q4 2013 and has held it in 36 quarters since. The position peaked at $1.1M in Q4 2013. 296 funds tracked by Wall St. Rank hold ABEV as of Q3 2022.

  • R.H. Bluestein & Co held 75,000 shares of Ambev worth $212K as of Q3 2022.
  • R.H. Bluestein & Co left its Ambev share count unchanged in Q3 2022.
  • Ambev made up 0.01% of R.H. Bluestein & Co's portfolio in Q3 2022, its #313 holding.
  • R.H. Bluestein & Co first reported a position in Ambev in Q4 2013 and has held it in 36 quarters since.
  • R.H. Bluestein & Co's Ambev position peaked at $1.1M in Q4 2013.
  • 296 funds tracked by Wall St. Rank held Ambev as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.